Targeting the CaV - interaction yields a selective antagonist of the N-type CaV2.2 channel with broad antinociceptive efficacy
Rajesh Khanna, Jie Yu, Xiao-Fang Yang, Aubin Moutal, Aude Chefdeville, Vijay M. Gokhale, Zunaira Shuja, Lindsey A. Chew, Shreya Sai Bellampalli, Shizhen Luo, Liberty François‐Moutal, Maria Serafini, Taehwan Ha, Samantha Perez‐Miller, Ki Duk Park, , May Khanna
The paper identifies a novel CaV2.2 channel antagonist with broad antinociceptive effects and reduced side effects in pain models.
Pain · Feb 5, 2019Peer-reviewedNeuroscience